This educational activity is intended for neurologists, neuromuscular specialists, pediatricians, geneticists, genetic counselors, physical and occupational therapists, nurse practitioners, physician associates, and other members of the health care team who care for patients with limb-girdle muscular dystrophy (LGMD).

PROGRAM OVERVIEW

The goal of this initiative is to address knowledge and competence gaps related to LGMD, specifically increasing awareness of existing genetic testing programs and available specialized care, achieving diagnosis earlier in the disease course, and evaluating ongoing clinical research for gene therapy as a potential treatment option.

An EXPLORE™ eLearning Module is an online educational program that has been uniquely designed by The France Foundation to allow for self-directed learning in a non-linear fashion, consisting of highly interactive elements, multimedia formats, and practical application tools, all developed in a micro-learning strategy.

• Identify existing LGMD genetic testing programs and determine appropriate patient pathways for receiving specialized care
• Recognize the importance of early diagnosis in LGMD and the consequences of missed or delayed diagnosis
• Assess how ongoing developments in clinical research with gene therapy may help address current limitations in the management of LGMD
  
  

FACULTY

Peter Kang, MD
Professor and Vice Chair of Research
Director, Paul and Sheila Wellstone Muscular Dystrophy Center
University of Minnesota Medical School
Minneapolis, Minnesota

Carla Zingariello, DO
Assistant Professor Pediatrics
Pediatric Neurology Residency Program
Director
University of Florida College of Medicine
Gainesville, Florida

PLANNING COMMITTEE

Peter Kang, MD
Professor and Vice Chair of Research
Director, Paul and Sheila Wellstone Muscular Dystrophy Center
University of Minnesota Medical School
Minneapolis, Minnesota

Carla Zingariello, DO
Assistant Professor Pediatrics
Pediatric Neurology Residency Program
Director
University of Florida College of Medicine
Gainesville, Florida

ACCREDITATION STATEMENT

In support of improving patient care, The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

CREDIT DESIGNATION

Physicians
The France Foundation designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses
The France Foundation designates this activity for 1.0 contact hours.

Physician Associates
The France Foundation has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit.

Approval is valid until October 11, 2024. PAs should only claim credit commensurate with the extent of their participation.

All other healthcare professionals completing this course will be issued a statement of participation.

DISCLOSURE POLICY
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, The France Foundation (TFF) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial entity. TFF resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. Furthermore, TFF seeks to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. TFF is committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.

Planning committee members, faculty, reviewers, and activity staff have disclosed the following relevant financial relationships. All relevant financial relationships listed have been mitigated.

TFF requires CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that are outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

This activity is supported by an independent medical educational grant from Sarepta Therapeutics, Inc.

The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and the commercial supporter(s) assume no liability for the information herein.

Copyright © 2023 The France Foundation. Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software ("Materials") found on the Site subject to the following terms, conditions, and exceptions:

• The materials are to be used solely for personal, noncommercial, informational, and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.

• Materials may not be published, uploaded, posted, or transmitted (other than as set forth herein) without The France Foundation's prior written permission